Evidence for centrally initiated genital vasocongestive engorgement in the female rat: Findings from a new model of female sexual arousal response

R. K S Beharry, Taben Hale, E. A A Wilson, J. P W Heaton, M. A. Adams

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Purpose: In spite of rapidly growing interest, few research tools have been developed to study female sexual dysfunction. Using the D1/D2 agonist, apomorphine (APO), our objective was to develop a new model of the sexual arousal response in female rats based on one previously established for the male condition. Methods: APO (80 μg/kg s.c.) was given during proestrus (P), estrus (E), metestrus (M), early diestrus (DI) and late diestrus (DII), and in ovariectomized (OVX) female Wistar rats. APO-induced behavioral and genital responses were characterized (30 min) using video monitoring. Results: APO-induced reproducible, periodic morphological changes in the external genitalia. The onset, timing and duration of these female APO responses were consistent with genital vasocongestive arousal (GVA) responses in males (ie erections). APO-induced GVAs occurred throughout the estrous cycle, peaking in E (1.4 + 1.21 overall; 0.9 + 0.64 in DII; 1.8 + 1.66 in E) and were markedly diminished by ovariectomy (OVX, 0.4 + 0.51). Conclusion: APO induced a reproducible sexual arousal response in female rats involving obvious genital vasocongestive engorgement. Further, the findings demonstrate that the APO-induced genital arousal responses are hormonally regulated.

Original languageEnglish (US)
Pages (from-to)122-128
Number of pages7
JournalInternational Journal of Impotence Research
Volume15
Issue number2
DOIs
StatePublished - Apr 2003
Externally publishedYes

Fingerprint

Apomorphine
Arousal
Diestrus
Metestrus
Proestrus
Genitalia
Estrous Cycle
Estrus
Ovariectomy
Wistar Rats
Research

Keywords

  • Apomorphine
  • Female sexual arousal
  • Female sexual dysfunction
  • Genital vasocongestive arousal
  • Hormones
  • Ovariectomy

ASJC Scopus subject areas

  • Urology

Cite this

Evidence for centrally initiated genital vasocongestive engorgement in the female rat : Findings from a new model of female sexual arousal response. / Beharry, R. K S; Hale, Taben; Wilson, E. A A; Heaton, J. P W; Adams, M. A.

In: International Journal of Impotence Research, Vol. 15, No. 2, 04.2003, p. 122-128.

Research output: Contribution to journalArticle

@article{b08b96ea20e44ab1b071bb9f42edae6b,
title = "Evidence for centrally initiated genital vasocongestive engorgement in the female rat: Findings from a new model of female sexual arousal response",
abstract = "Purpose: In spite of rapidly growing interest, few research tools have been developed to study female sexual dysfunction. Using the D1/D2 agonist, apomorphine (APO), our objective was to develop a new model of the sexual arousal response in female rats based on one previously established for the male condition. Methods: APO (80 μg/kg s.c.) was given during proestrus (P), estrus (E), metestrus (M), early diestrus (DI) and late diestrus (DII), and in ovariectomized (OVX) female Wistar rats. APO-induced behavioral and genital responses were characterized (30 min) using video monitoring. Results: APO-induced reproducible, periodic morphological changes in the external genitalia. The onset, timing and duration of these female APO responses were consistent with genital vasocongestive arousal (GVA) responses in males (ie erections). APO-induced GVAs occurred throughout the estrous cycle, peaking in E (1.4 + 1.21 overall; 0.9 + 0.64 in DII; 1.8 + 1.66 in E) and were markedly diminished by ovariectomy (OVX, 0.4 + 0.51). Conclusion: APO induced a reproducible sexual arousal response in female rats involving obvious genital vasocongestive engorgement. Further, the findings demonstrate that the APO-induced genital arousal responses are hormonally regulated.",
keywords = "Apomorphine, Female sexual arousal, Female sexual dysfunction, Genital vasocongestive arousal, Hormones, Ovariectomy",
author = "Beharry, {R. K S} and Taben Hale and Wilson, {E. A A} and Heaton, {J. P W} and Adams, {M. A.}",
year = "2003",
month = "4",
doi = "10.1038/sj.ijir.3900980",
language = "English (US)",
volume = "15",
pages = "122--128",
journal = "International Journal of Impotence Research",
issn = "0955-9930",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Evidence for centrally initiated genital vasocongestive engorgement in the female rat

T2 - Findings from a new model of female sexual arousal response

AU - Beharry, R. K S

AU - Hale, Taben

AU - Wilson, E. A A

AU - Heaton, J. P W

AU - Adams, M. A.

PY - 2003/4

Y1 - 2003/4

N2 - Purpose: In spite of rapidly growing interest, few research tools have been developed to study female sexual dysfunction. Using the D1/D2 agonist, apomorphine (APO), our objective was to develop a new model of the sexual arousal response in female rats based on one previously established for the male condition. Methods: APO (80 μg/kg s.c.) was given during proestrus (P), estrus (E), metestrus (M), early diestrus (DI) and late diestrus (DII), and in ovariectomized (OVX) female Wistar rats. APO-induced behavioral and genital responses were characterized (30 min) using video monitoring. Results: APO-induced reproducible, periodic morphological changes in the external genitalia. The onset, timing and duration of these female APO responses were consistent with genital vasocongestive arousal (GVA) responses in males (ie erections). APO-induced GVAs occurred throughout the estrous cycle, peaking in E (1.4 + 1.21 overall; 0.9 + 0.64 in DII; 1.8 + 1.66 in E) and were markedly diminished by ovariectomy (OVX, 0.4 + 0.51). Conclusion: APO induced a reproducible sexual arousal response in female rats involving obvious genital vasocongestive engorgement. Further, the findings demonstrate that the APO-induced genital arousal responses are hormonally regulated.

AB - Purpose: In spite of rapidly growing interest, few research tools have been developed to study female sexual dysfunction. Using the D1/D2 agonist, apomorphine (APO), our objective was to develop a new model of the sexual arousal response in female rats based on one previously established for the male condition. Methods: APO (80 μg/kg s.c.) was given during proestrus (P), estrus (E), metestrus (M), early diestrus (DI) and late diestrus (DII), and in ovariectomized (OVX) female Wistar rats. APO-induced behavioral and genital responses were characterized (30 min) using video monitoring. Results: APO-induced reproducible, periodic morphological changes in the external genitalia. The onset, timing and duration of these female APO responses were consistent with genital vasocongestive arousal (GVA) responses in males (ie erections). APO-induced GVAs occurred throughout the estrous cycle, peaking in E (1.4 + 1.21 overall; 0.9 + 0.64 in DII; 1.8 + 1.66 in E) and were markedly diminished by ovariectomy (OVX, 0.4 + 0.51). Conclusion: APO induced a reproducible sexual arousal response in female rats involving obvious genital vasocongestive engorgement. Further, the findings demonstrate that the APO-induced genital arousal responses are hormonally regulated.

KW - Apomorphine

KW - Female sexual arousal

KW - Female sexual dysfunction

KW - Genital vasocongestive arousal

KW - Hormones

KW - Ovariectomy

UR - http://www.scopus.com/inward/record.url?scp=0038238341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038238341&partnerID=8YFLogxK

U2 - 10.1038/sj.ijir.3900980

DO - 10.1038/sj.ijir.3900980

M3 - Article

C2 - 12789392

AN - SCOPUS:0038238341

VL - 15

SP - 122

EP - 128

JO - International Journal of Impotence Research

JF - International Journal of Impotence Research

SN - 0955-9930

IS - 2

ER -